Sam Altman’s Life Extension Guy Warns of Injections That Cause Wild Tumor Growth
In a daring move, OpenAI CEO Sam Altman is investing a staggering $180 million in Retro Biosciences, a startup aiming to discover innovative methods to extend human longevity. Retro Biosciences utilizes a risky approach by concurrently investigating five diverse areas of anti-aging science. Despite the hefty investment and optimistic ambitions, the research is fraught with […]